midodrine has been researched along with Chylothorax in 3 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Chylothorax: The presence of chyle in the thoracic cavity. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Tamaoka, S | 1 |
| Osada, A | 1 |
| Kin, T | 1 |
| Arimitsu, T | 1 |
| Hida, M | 1 |
| Sivakumar, P | 1 |
| Ahmed, L | 1 |
| Liou, DZ | 1 |
| Warren, H | 1 |
| Maher, DP | 1 |
| Soukiasian, HJ | 1 |
| Melo, N | 1 |
| Salim, A | 1 |
| Ley, EJ | 1 |
3 other studies available for midodrine and Chylothorax
| Article | Year |
|---|---|
Midodrine, an Oral Alpha-1 Adrenoreceptor Agonist, Successfully Treated Refractory Congenital Chylous Pleural Effusion and Ascites in a Neonate.
Topics: Adrenergic alpha-1 Receptor Agonists; Adult; Chylothorax; Chylous Ascites; Female; Humans; Infant, N | 2021 |
Use of an Alpha-1 Adrenoreceptor Agonist in the Management of Recurrent Refractory Idiopathic Chylothorax.
Topics: Adrenergic alpha-1 Receptor Agonists; Aged; Chylothorax; Female; Follow-Up Studies; Humans; Midodrin | 2018 |
Midodrine: a novel therapeutic for refractory chylothorax.
Topics: Adenocarcinoma; Chylothorax; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans; | 2013 |